Department of Practice and Policy, School of Pharmacy, University College London, London, UK; International Pharmaceutical Federation, The Hague, Netherlands.
International Pharmaceutical Federation, The Hague, Netherlands.
Res Social Adm Pharm. 2024 Dec;20(12 Pt A):1118-1124. doi: 10.1016/j.sapharm.2024.09.002. Epub 2024 Sep 12.
In light of the expanding role of pharmacy in addressing global health challenges of Universal Health Coverage, advancing pharmacy practice to provide more effective pharmaceutical services has become imperative. This study aims to develop and validate a global goals-oriented pharmaceutical development framework to support and guide a systematic practice transformation that can widen access to better health for all.
A mixed methods approach was used to conduct a series of exploration, development, and consensus phases. The exploratory stage included desk research focused on innovative pharmaceutical provision globally. Focus groups with 14 international pharmacists were held, selected via convenience sampling, to obtain primary data on perceptions of the proposed global FIP "Development Goals" framework. The consultation stage was followed by a modified nominal group technique (mNGT) with 61 global pharmacy leaders from 35 countries across six WHO regions, selected through purposive sampling, to further develop the content of the framework's first iteration. Lastly, an online two-round modified Delphi approach with 28 global pharmacy leaders, also selected via purposive sampling, was used to ensure the credibility and content validity of the outputs, generating consensus on the final framework matrix.
The exploratory stage produced a draft set of 13 unvalidated FIP Practice Development Goals (DGs) Framework (v0). Initial analysis of the mNGT showed complex intersections between the proposed set of goals, necessitating further modifications by embedding the previously published global Pharmaceutical Workforce Development Goals framework. This resulted in an amended FIP DGs Framework (v1) with 21 DGs. The evidence-led adjustment and distinctive format of the global consensus stage helped generate the validated, systematic FIP DGs Framework (final version), comprising 21 discrete global development goals ready for policy deployment.
A systematic goals-oriented development framework was developed to respond to pharmaceutical development needs and support a needs-based roadmap for a sustainable pharmacy practice transformation globally, regionally and nationally.
鉴于药剂师在实现全民健康覆盖的全球健康挑战方面发挥的作用不断扩大，推进药剂实践以提供更有效的药物服务已变得势在必行。本研究旨在制定和验证一个以全球目标为导向的药物开发框架，以支持和指导系统实践的转变，从而为所有人提供更好的健康服务。
采用混合方法，进行了一系列探索、发展和共识阶段。探索阶段包括针对全球创新药物供应的案头研究。通过便利抽样，对 14 名国际药剂师进行了焦点小组访谈，以获取对拟议的全球 FIP“发展目标”框架的初步看法。随后是咨询阶段，采用改良名义群体技术（mNGT），对来自六个世卫组织区域 35 个国家的 61 名全球药剂师进行了咨询，这些参与者是通过目的性抽样选择的，以进一步制定该框架的第一版内容。最后，采用在线两轮改良 Delphi 法，对来自六个世卫组织区域 35 个国家的 28 名全球药剂师进行了咨询，这些参与者也是通过目的性抽样选择的，以确保产出的可信度和内容有效性，就最终框架矩阵达成共识。
探索阶段产生了一套未经验证的 13 项 FIP 实践发展目标（DG）框架草案（v0）。对 mNGT 的初步分析表明，拟议目标集之间存在复杂的交集，需要通过嵌入先前发表的全球药物行业人力资源发展目标框架进行进一步修改。这导致了一个修正的 FIP DG 框架（v1），其中有 21 项 DG。全球共识阶段的循证调整和独特格式有助于生成经过验证的、系统的 FIP DG 框架（最终版本），其中包含 21 项离散的全球发展目标，可用于政策部署。
制定了一个系统的以目标为导向的发展框架，以满足药物开发需求，并支持在全球、区域和国家层面进行基于需求的可持续药剂实践转变的路线图。
